Parvovirus VLP VP1/VP2 Co-Capsid Parvovirus Recombinant Protein

Recombinant Parvovirus B19 VLP VP1/VP2 Co-Capsid produced in SF9 containing B19 capsid proteins VP1 (86,049 Dalton) and VP2 (60,839 Dalton).Parvovirus B19 VLP VP1/VP2 is purified by proprietary chromatographic techniques.

Small volumes of Parvovirus VLP VP1/VP2 Co-Capsid recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Parvoviruses are a family of very small DNA viruses known to cause both animal and human disease. Parvovirus B19 VLP VP1 VP2 is the causative factor for erythema infectiosum - a major parental headache. Research studies into virus transmission and molecular biology are aided by a B19 virus recombinant VP2 capsid protein from MyBiosource. This and similar proteins are derived from Sf9 insect cells and purified for use as antigens in generation of monoclonal antibody production for ELISA or other antibodies- based custom applications. Highly stable with long shelf life when freeze thaw cycles are avoided, this recombinant parvovirus is part of a series of recombinant parvovirus antigen reagents which are ideal for development of assays, antibody arrays (positive control) and ELISA kits. Recombinant parvovirus B19 is shipped in PBS NaCl 20 glycerol% buffer and is sterile filtered for long term storage. Order the quantity that best fits your needs.